Pharmacokinetics and metabolism of [3H]-pipethiaden in healthy volunteers
- 9 Downloads
Six healthy volunteers participated in a single-dose study of pharmacokinetics and metabolism of oral administration of [3H]-pipethiaden (1 mg). Plasma levels of total radioactivity, urinary excretion and metabolism were analyzed by liquid scintillation counting and radio-TLC. The mean peak plasma concentration of radioactive metabolites was 4.9 ng eq/ml, and the mean elimination half life was 11.5 h. 34% of radioactivity was recovered in 4 days in urine, with only 0.4% present as unchanged drug. Pipethiaden was extensively metabolized by S-oxidation, N-demethylation, and N-oxidation.
Keywords[3H]-Pipethiaden pharmacokinetics metabolism
Unable to display preview. Download preview PDF.
- 1.Rajšner M., Metyš J., Protiva M. (1967): Neurotrope and Psychotrope Substanzen. XV. 4,9-Dihydrothieno [2,3-b] benzo[e]thiepin-Derivative. Collect Czech. Chem. Commun., 32, 2854–2866.Google Scholar
- 2.Metyš J., Metyšová J., Valchát M, Dlabac A. (1979): Pharmacological characteristics of several new antimigraine compounds. Cs. Fysiol., 28, 270–271.Google Scholar
- 3.Metyšová J., Metyš J. (1979): Comparative studies of new anti-migraine drugs. I. Action on central nervous system in rodents. Activ. Nerv. Sup. (Praha), 21, 174–175.Google Scholar
- 6.Yamaoka K., Tanigawara Y., Nakagawa T., Uno T. (1981): A pharmacokinetic analysis program (MULTI) for microcomputer. J. Pharm. Dyn., 4, 879–885.Google Scholar
- 8.Metyš J., Dlohožková N., Soucek R., et al. (1989) Pharmacological properties of the metabolites of pipethiaden, a novel anti-migraine prophylactic agent. Cs. Fysiol., 38, 160.Google Scholar